Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

Quon Harvey C.; Ong Aldrich; Cheung Patrick; Chu William; Chung Hans T.; Vesprini Danny; Chowdhury Amit; Panjwani Dilip; Pang Geordi; Korol Renee; Davidson Melanie; Ravi Ananth; McCurdy Boyd; Zhang Liying; Mamedov Alexandre; Deabreu Andrea; Loblaw Andrew

首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

【24h】

Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

机译：每周对前列腺癌（爱国者）患者的每周每周一周的立体定位身体放射治疗：第2期随机试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and purpose: Prostate stereotactic body radiotherapy (SBRT) regimens differ in time, dose, and fractionation. We completed a multicentre, randomized phase II study to investigate the impact of overall treatment time on quality of life (QOL).

机译：背景和目的：前列腺定向体放射疗法（SBRT）方案随时间，剂量和分馏而异。我们完成了一项多方形，随机期二期的研究，调查整体治疗时间对生活质量（QOL）的影响。

著录项

来源
《Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology》 |2018年第2期|共7页
作者
Quon Harvey C.; Ong Aldrich; Cheung Patrick; Chu William; Chung Hans T.; Vesprini Danny; Chowdhury Amit; Panjwani Dilip; Pang Geordi; Korol Renee; Davidson Melanie; Ravi Ananth; McCurdy Boyd; Zhang Liying; Mamedov Alexandre; Deabreu Andrea; Loblaw Andrew;
展开▼
作者单位

Tom Baker Canc Clin 1331-29 St NW Calgary AB T2N 4N2 Canada;

CancerCare Manitoba Winnipeg MB Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

CancerCare Manitoba Winnipeg MB Canada;

BC Canc Agcy Abbotsford BC Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

CancerCare Manitoba Winnipeg MB Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

Sunnybrook Hlth Sci Ctr Odette Canc Ctr Toronto ON Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Prostatic neoplasms; Radiosurgery; Stereotactic body radiotherapy; Randomized controlled trial; Quality of life; Toxicity;

机译：前列腺肿瘤;放射外科;立体定向体放射治疗;随机对照试验;生活质量;毒性;

相似文献

外文文献
中文文献
专利

1. Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial [J] . Quon Harvey C., Ong Aldrich, Cheung Patrick, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2018,第2期

机译：每周对前列腺癌（爱国者）患者的每周每周一周的立体定位身体放射治疗：第2期随机试验
2. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial [J] . Brand Douglas H., Tree Alison C., Ostler Peter, The lancet oncology . 2019,第11期

机译：强度调节的分级放射治疗与前列腺癌的立体定向身体放射疗法（PACE-B）：来自国际，随机，开放标签，第3阶段，非劣级试验的急性毒性结果
3. Patient Reported Acute Toxicity in PACE-B, an International Phase III Randomised Controlled Trial Comparing Stereotactic Body Radiotherapy to Conventionally Fractionated or Moderately Hypofractionated Radiotherapy (CFMHRT) for Localised Prostate Cancer [J] . Brand D. H., Tree A., Ostler P., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：患者报告了Pace-B中的急性毒性，将局部前列腺体放射治疗的国际阶段III随机对照试验比较局部前列腺癌（CFMHRT）对比较的立体定向体放射治疗
4. ~(18)F-NaF PET/CT-directed dose escalation in stereotactic body radiotherapy for spine oligometastases from prostate cancer [C] . L. Wu, S.A. Kwee, M. Li World Congress on Medical Physics and Biomedical Engineering . 2015

机译：〜（18）F-NAF PET / CT定向剂量升级在前列腺癌中脊柱脱硫菌的立体定向体放射疗法
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial [O] . Ting Martin Ma, James M. Lamb, Maria Casado, 2021

机译：磁共振成像引导的前列腺癌的立体定向体放射治疗（Mirage）：III期随机试验
7. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial [O] . Douglas H Brand, Alison C Tree, Peter Ostler, 2019

机译：强度调节分级放射治疗与前列腺癌的立体定向体放射治疗（PACE-B）：来自国际，随机，开放标签，第3阶段，非劣级审判的急性毒性结果
8. Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High Risk Castrate, Biochemically Relapsed Prostate Cancer. [R] . Tagawa, S. T. 2017

机译：177Lu放射性标记的抗psma单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验。

Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

摘要

著录项

相似文献

相关主题

期刊订阅